Sumitomo Dainippon Pharma Co Ltd

Overview

Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co Ltd develops, manufactures, sells, imports and exports pharmaceutical products. The company drugs are focused on major therapeutic areas which include regenerative diseases, oncology, psychiatry and neurology and infectious diseases. It also offers veterinary products, food additives, chemical product materials, food ingredients, cosmetic materials and other products. Sumitomo Dainippon has research laboratories, manufacturing and distribution facilities in Japan. The company operates through subsidiaries and offices in the North America, Europe and Asia Pacific. Sumitomo Dainippon is headquartered in Chuo-ku, Osaka, Japan.
Key Stats
Address
2-6-8, Dosho-machi, Chuo-ku, Chuo-ku, OSAKA-SHI, Osaka
Headquarters

Japan

Contact

81 6 62035321

No of Employees

6,822

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

4506 [TYO]

Revenue (2021)

$4,867 m

6.9% (2021 vs 2020)
Net Income (2021)

$530 m

37.9% (2021 vs 2020)
Net Profit Margin

11 %

29.2% (2021 vs 2020)
Market Cap *

$7,641 m

EPS *

$1.3

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Sumitomo Dainippon Pharma Co LtdTakeda Pharmaceutical Co LtdAstellas Pharma IncDaiichi Sankyo Co Ltd
Key Information
Headquarters Japan Japan Japan Japan
Headquarter City OSAKA-SHI CHUO-KU CHUO-KU CHUO-KU
Headquarter State/Province Osaka Tokyo Tokyo Tokyo
No. of Employees 6,822 47,099 15,455 16,033
Entity Type Public Public Public Public

Products & Services

Sumitomo Dainippon Pharma manufactures and markets pharmaceuticals, veterinary medicines food ingredients, food additives and others. The company's major products include the following:

Products
  • Pharmaceuticals:
  • Oncology Drugs
  • Psychiatry and Neurology Drugs
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • API Biologics (Cell, Gene, Vaccine and Virus)
  • API Chemical
Brands
  • Gemtesa
  • Latuda
  • Equa/EquMet
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Toru Kimura Director; Chief Scientific Officer - Regenerative & Cellular Medicine Office; Regenerative and Cellular Medicine Kobe Center; Regenerative and Cellular Medicine Manufacturing Plant; Executive Vice President Executive Board 2021 - Mr. Toru Kimura has been a Director, Executive Officer, Chief Scientific Officer, Regenerative & Cellular Medicine Office; Regenerative & Cellular...
Hiroshi Nomura Director; Chief Executive Officer; President Executive Board 2018 - Mr. Hiroshi Nomura has been the Director, the President and the Chief Executive Officer of the company since 2018. Previously,...
Masayo Tada Chairman Executive Board - - Mr. Masayo Tada is the Chairman of the company. Prior to this, he served as the Chief Executive Officer of...
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 New Products/Services In April, the company's subsidiary Urovant Sciences launched Gemtesa (vibegron) tablets for the treatment of…
2021 Contracts/Agreements In June, Sumitomo Dainippon entered into a collaborative research and development agreement with Nippon Chemiphar…
2021 New Product Approvals In May, the company's subsidiary Myovant Sciences and Pfizer jointly received approval from the US…
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Sumitomo Dainippon Pharma Oncology, Inc

Address

640 Memorial Drive, Cambridge
United States of America

Telephone

1 617 6746800

Website

www.sdponcology.com
Sunovion Pharmaceuticals Inc

Address

84 Waterford Drive, Marlborough
United States of America

Telephone

1 508 4816700

Website

www.sunovion.com
Marupi Lifetech Co Ltd

Address

103, Fushio-cho, Ikeda
Japan

Telephone

81 727 530335

Tolero Pharmaceuticals Inc

Address

Suite 100, 3900 North Traverse Mountain Boulevard, Lehi
United States of America

Telephone

1 801 7690796

Website

www.toleropharma.com
DS Pharma Animal Health Co Ltd

Address

5-51, Ebie 1-chome, Fukushima-ku, Osaka City
Japan

Telephone

81 6 64548823

Sumitomo Pharmaceuticals (Suzhou) Co Ltd

Address

No. 115, QingQiu Street, Suzhou
China

Telephone

86 512 62831082

Website

www.dsmpharm.com.cn
DSP Distribution Service Co Ltd

Address

5-51, Ebie 1-chome, Fukushima-ku, Osaka
Japan

Telephone

81 6 64583179

DSP Gokyo Food & Chemical Co., Ltd.

Address

5-51, Ebie 1-chome, Fukushima-ku, Osaka, Osaka City
Japan

Telephone

81 6 62027691

Website

www.dsp-gokyo-fc.co.jp

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target

Jobs Overview

139

Active Jobs

25

Posted

23

Closed

Job Trends

Latest Jobs

Job title Company Country
Procurement / Purchasing Staff for Pharmaceutical Raw Materials Research Institute Sumitomo Dainippon Pharma Co Ltd Japan
Drug Development Project Leader (Oncology Area) Tokyo Headquarters Sumitomo Dainippon Pharma Co Ltd India
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar